Background: Mohs micrographic surgery causes significant postsurgical pain, particularly when more extensive reconstructions are required. Although opioids are a reasonable choice for pain control in select cases, the risks of dependency and overdose warrant stringent opioid stewardship.
Objective: To determine how the opioid prescribing practices among Mohs surgeons treating Medicare beneficiaries have changed during the opioid epidemic using the available Medicare claims data from 2014 to 2022.
Methods: A retrospective analysis of opioid prescribing using Medicare claims data.
Results: Between 2014 and 2022, the percent of Mohs surgeons prescribing opioids decreased from 48% to 33%. Factors associated with opioid prescribing included medical school graduation in 1990 or after; location in the South, Midwest, or West; higher Mohs case volume; and performing higher complexity repairs. Surgeons prescribing opioids decreased the average days' supply by 19%. The percent of opioid prescriptions for hydrocodone decreased by 28% while those for tramadol increased by 246%.
Conclusion: Mohs surgeons' opioid prescribing practices have continued to improve since 2014 through limiting the frequency and duration of opioid prescriptions, with most surgeons not prescribing opioids in 2022.
扫码关注我们
求助内容:
应助结果提醒方式:
